期刊文献+

98例耐多药结核病患者治疗管理依从性单因素分析 被引量:2

Univariate analysis of the factors affecting treatment compliance of 98 multidrug-resistant tuberculosis patients
原文传递
导出
摘要 目的探讨耐多药结核病患者治疗管理依从性的影响因素。方法于2007-2009年对河南省12个市级结核病防治机构治疗满一年的98例耐多药肺结核病患者治疗进行问卷调查,利用卡方对影响治疗依从性的可能因素进行单因素分析。结果观察1年的治疗,耐药种类、不良反应的发生、交通不便、经济困难、结核病防治知识的知晓情况对患者治疗管理依从性均有影响,其对比均有显著性差异。结论耐多药结核病患者依从性受多种因素的影响,积极采取相应对策,可以提高耐多药肺结核患者的治疗依从性,降低治疗失败率和病死率。 Objective To explore influencing factors on compliance of multidrug-resistant tuberculosis(MDR-TB)treatment. Methods From January 2007 to December 2009, questionnaire survey on 98 cases of MDR-TB patients treated in one year, x2 was adopted to analyze the factors affecting compliance of MDR-TB treatment. Results Types of drug resistant, adverse reactions, inconvenient transportation, economic difficulties, awareness of TB Knowledge, were risk factors for compliance of MDR-TB patients treatment and management. Conclusion Many factors could affect the compliance of MDR-TB treatment and management, took appropriate countermeasures could improve treatment compliance and reduce treatment failure and mortality of MDR-TB.
出处 《河南预防医学杂志》 2014年第4期241-243,257,共4页 Henan Journal of Preventive Medicine
关键词 肺结核病 耐多药 依从性 Pulmonary tuberculosis Multidrug-resistant tuberculosis theatment compliance
  • 相关文献

参考文献6

  • 1World Health Organization. Global tuberculosis control: epidemiology, strategy, financing [Z]. WHO Report 2009.
  • 2Geneva: WHO, 2009. World Health Organization. Multidrug and extensivelydrug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response [Z]. WHO/HTM/TB/2010.3. Geneva: World Health Organization, 2010.
  • 3张立兴,屠德华.加强预防和合理治疗耐多药结核病[J].中国防痨杂志,2003,25(1):2-3. 被引量:50
  • 4Espinal MA et al. Rational'DOTS plus'for the control of MDR-TB [J]. International Journal of Tuberculosis and Lung Disease, 1999,3 (7):561-563.
  • 5Mitchison DA.How drug resistance emerges as a result of poor compliance during short course chemotherapy for tu- berculosis [J]. International Journal of Tuberculosis and Lung Disease,1998,2(1):5-10.
  • 6Chaulk CP et al. Treating muhidrug-resistant tuberculosis: compliance and side effects [J]. Journal of the American Medical Associatiosis, 1994,271 (2): 103-104.

二级参考文献1

共引文献49

同被引文献30

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部